French Renewable Energy Stock News

ENXTPA:MEDCL
ENXTPA:MEDCLPharmaceuticals

MedinCell (ENXTPA:MEDCL): Assessing Valuation After Teva’s FDA Filing for Olanzapine Long-Acting Injectable

MedinCell (ENXTPA:MEDCL) has been in focus after partner Teva filed a New Drug Application with the U.S. FDA for its olanzapine long acting injectable, which is built on MedinCell’s BEPO technology. See our latest analysis for MedinCell. The latest regulatory milestone appears to have reignited interest in MedinCell, with the 1 day share price return of 3.85 percent and a 90 day share price return of 41.39 percent contributing to a robust 1 year total shareholder return of 77.19 percent. This...
ENXTPA:ERF
ENXTPA:ERFLife Sciences

Is Eurofins Scientific Fairly Priced After Portfolio Streamlining and 2025 Share Price Rebound?

If you have been wondering whether Eurofins Scientific is still a quality stock at a fair price, you are not alone, as many investors are trying to figure out if the current share price matches its long term potential. Despite a choppy few weeks, with the share price down 4.4% over the last 7 days and 2.6% over the last month, Eurofins is still up 16.3% year to date and 20.2% over the past year. This hints that the market may be warming back up to its story after a tougher 3 and 5 year...
ENXTPA:INF
ENXTPA:INFIT

European Dividend Stocks To Consider In December 2025

As the European market experiences mixed returns with a slight uptick in the STOXX Europe 600 Index amid hopes for interest rate cuts, investors are keenly observing inflation trends and economic growth revisions across the region. In this dynamic environment, dividend stocks can offer stability and income potential, making them a compelling consideration for those looking to navigate these uncertain times.
ENXTPA:ASY
ENXTPA:ASYProfessional Services

Assystem And 2 More European Companies Estimated To Be Priced Below Their Intrinsic Value

As European markets continue to show resilience, with the STOXX Europe 600 Index rising by 2.35% and major single-country indexes also posting gains, investors are increasingly focused on finding opportunities that may be undervalued amidst a relatively stable inflation environment. In such conditions, stocks that are priced below their intrinsic value present an attractive proposition for those looking to capitalize on potential market inefficiencies and long-term growth prospects.
ENXTPA:ANTIN
ENXTPA:ANTINCapital Markets

European Stocks That May Be Trading Below Estimated Value

As European markets continue to show resilience, with the STOXX Europe 600 Index and major single-country indexes posting gains, investors are increasingly focused on identifying stocks that may be trading below their estimated value. In such a climate, a good stock is often characterized by strong fundamentals and potential for growth, making it an attractive option for those looking to capitalize on market opportunities.